Modeling asthma and COPD in animals: A pointless exercise?

Research output: Contribution to journalArticle

Abstract

Animal modeling has been essential to the development of every drug used to treat asthma and chronic obstructive pulmonary disease (COPD). Determining the safety and efficacy of new therapeutics will also depend upon animal experimentation, and future targets for therapeutic intervention will probably be identified during careful experimentation using animals. Animal modeling of chronic diseases is made possible by the fact that the processes associated with the regulation of breathing, gas exchange, airway smooth-muscle contraction and relaxation, blood flow through the pulmonary and bronchial vasculature, inflammatory cell recruitment, mucus secretion, mucociliary clearance and airway surface liquid composition are highly conserved in mammals. This conservation is apparent at the whole-organ level and also at the level of the cell and the genome. The subtleties of how the airways and lungs are regulated and experimentally measured in different species make the more complex processes associated with asthma and COPD difficult to faithfully model or duplicate in mammals, particularly in mammals such as rodents that are only distantly related to humans.

Original languageEnglish (US)
Pages (from-to)244-250
Number of pages7
JournalCurrent Opinion in Pharmacology
Volume3
Issue number3
DOIs
StatePublished - Jun 2003

Fingerprint

Chronic Obstructive Pulmonary Disease
Mammals
Asthma
Mucociliary Clearance
Lung
Muscle Relaxation
Mucus
Muscle Contraction
Smooth Muscle
Rodentia
Respiration
Chronic Disease
Gases
Genome
Safety
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Modeling asthma and COPD in animals : A pointless exercise? / Canning, Brendan J.

In: Current Opinion in Pharmacology, Vol. 3, No. 3, 06.2003, p. 244-250.

Research output: Contribution to journalArticle

@article{84130badc8e24fc9b5e8ea7293cb6b57,
title = "Modeling asthma and COPD in animals: A pointless exercise?",
abstract = "Animal modeling has been essential to the development of every drug used to treat asthma and chronic obstructive pulmonary disease (COPD). Determining the safety and efficacy of new therapeutics will also depend upon animal experimentation, and future targets for therapeutic intervention will probably be identified during careful experimentation using animals. Animal modeling of chronic diseases is made possible by the fact that the processes associated with the regulation of breathing, gas exchange, airway smooth-muscle contraction and relaxation, blood flow through the pulmonary and bronchial vasculature, inflammatory cell recruitment, mucus secretion, mucociliary clearance and airway surface liquid composition are highly conserved in mammals. This conservation is apparent at the whole-organ level and also at the level of the cell and the genome. The subtleties of how the airways and lungs are regulated and experimentally measured in different species make the more complex processes associated with asthma and COPD difficult to faithfully model or duplicate in mammals, particularly in mammals such as rodents that are only distantly related to humans.",
author = "Canning, {Brendan J}",
year = "2003",
month = "6",
doi = "10.1016/S1471-4892(03)00045-6",
language = "English (US)",
volume = "3",
pages = "244--250",
journal = "Current Opinion in Pharmacology",
issn = "1471-4892",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - Modeling asthma and COPD in animals

T2 - A pointless exercise?

AU - Canning, Brendan J

PY - 2003/6

Y1 - 2003/6

N2 - Animal modeling has been essential to the development of every drug used to treat asthma and chronic obstructive pulmonary disease (COPD). Determining the safety and efficacy of new therapeutics will also depend upon animal experimentation, and future targets for therapeutic intervention will probably be identified during careful experimentation using animals. Animal modeling of chronic diseases is made possible by the fact that the processes associated with the regulation of breathing, gas exchange, airway smooth-muscle contraction and relaxation, blood flow through the pulmonary and bronchial vasculature, inflammatory cell recruitment, mucus secretion, mucociliary clearance and airway surface liquid composition are highly conserved in mammals. This conservation is apparent at the whole-organ level and also at the level of the cell and the genome. The subtleties of how the airways and lungs are regulated and experimentally measured in different species make the more complex processes associated with asthma and COPD difficult to faithfully model or duplicate in mammals, particularly in mammals such as rodents that are only distantly related to humans.

AB - Animal modeling has been essential to the development of every drug used to treat asthma and chronic obstructive pulmonary disease (COPD). Determining the safety and efficacy of new therapeutics will also depend upon animal experimentation, and future targets for therapeutic intervention will probably be identified during careful experimentation using animals. Animal modeling of chronic diseases is made possible by the fact that the processes associated with the regulation of breathing, gas exchange, airway smooth-muscle contraction and relaxation, blood flow through the pulmonary and bronchial vasculature, inflammatory cell recruitment, mucus secretion, mucociliary clearance and airway surface liquid composition are highly conserved in mammals. This conservation is apparent at the whole-organ level and also at the level of the cell and the genome. The subtleties of how the airways and lungs are regulated and experimentally measured in different species make the more complex processes associated with asthma and COPD difficult to faithfully model or duplicate in mammals, particularly in mammals such as rodents that are only distantly related to humans.

UR - http://www.scopus.com/inward/record.url?scp=0038177928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038177928&partnerID=8YFLogxK

U2 - 10.1016/S1471-4892(03)00045-6

DO - 10.1016/S1471-4892(03)00045-6

M3 - Article

C2 - 12810187

AN - SCOPUS:0038177928

VL - 3

SP - 244

EP - 250

JO - Current Opinion in Pharmacology

JF - Current Opinion in Pharmacology

SN - 1471-4892

IS - 3

ER -